FI20012082A0 - Biologiskt aktiva peptider för korrigering av nervskador - Google Patents

Biologiskt aktiva peptider för korrigering av nervskador

Info

Publication number
FI20012082A0
FI20012082A0 FI20012082A FI20012082A FI20012082A0 FI 20012082 A0 FI20012082 A0 FI 20012082A0 FI 20012082 A FI20012082 A FI 20012082A FI 20012082 A FI20012082 A FI 20012082A FI 20012082 A0 FI20012082 A0 FI 20012082A0
Authority
FI
Finland
Prior art keywords
biologically active
correction
active peptides
nerve damage
laminin
Prior art date
Application number
FI20012082A
Other languages
English (en)
Finnish (fi)
Inventor
Paeivi Liesi
Original Assignee
Paeivi Liesi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paeivi Liesi filed Critical Paeivi Liesi
Priority to FI20012082A priority Critical patent/FI20012082A0/sv
Publication of FI20012082A0 publication Critical patent/FI20012082A0/sv
Priority to CA2465245A priority patent/CA2465245C/en
Priority to US10/492,850 priority patent/US20040266991A1/en
Priority to DK02770017.8T priority patent/DK1438329T3/da
Priority to DE60238551T priority patent/DE60238551D1/de
Priority to PCT/FI2002/000831 priority patent/WO2003035675A1/en
Priority to AT02770017T priority patent/ATE490972T1/de
Priority to JP2003538188A priority patent/JP4312054B2/ja
Priority to EP02770017A priority patent/EP1438329B1/en
Priority to AU2002336124A priority patent/AU2002336124B2/en
Priority to US11/127,206 priority patent/US7659255B2/en
Priority to US12/141,129 priority patent/US7741436B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FI20012082A 2001-10-26 2001-10-26 Biologiskt aktiva peptider för korrigering av nervskador FI20012082A0 (sv)

Priority Applications (12)

Application Number Priority Date Filing Date Title
FI20012082A FI20012082A0 (sv) 2001-10-26 2001-10-26 Biologiskt aktiva peptider för korrigering av nervskador
AU2002336124A AU2002336124B2 (en) 2001-10-26 2002-10-25 Biologically active peptides and their use for repairing injured nerves
DE60238551T DE60238551D1 (de) 2001-10-26 2002-10-25 Biologisch aktive peptide und deren verwendung zur reparatur verletzter nerven
US10/492,850 US20040266991A1 (en) 2001-10-26 2002-10-25 Biologically active peptides and their use for repairing injured nerves
DK02770017.8T DK1438329T3 (da) 2001-10-26 2002-10-25 Biologisk aktive peptider og deres anvendelse til reparation af beskadigede nerver
CA2465245A CA2465245C (en) 2001-10-26 2002-10-25 Biologically active peptides and their use for repairing injured nerves
PCT/FI2002/000831 WO2003035675A1 (en) 2001-10-26 2002-10-25 Biologically active peptides and their use for repairing injured nerves
AT02770017T ATE490972T1 (de) 2001-10-26 2002-10-25 Biologisch aktive peptide und deren verwendung zur reparatur verletzter nerven
JP2003538188A JP4312054B2 (ja) 2001-10-26 2002-10-25 生物学的活性ペプチドおよびそれを用いた損傷神経の修復
EP02770017A EP1438329B1 (en) 2001-10-26 2002-10-25 Biologically active peptides and their use for repairing injured nerves
US11/127,206 US7659255B2 (en) 2001-10-26 2005-05-12 Methods of inhibiting glutamate receptors by administering the tripeptide KDI
US12/141,129 US7741436B2 (en) 2001-10-26 2008-06-18 Biologically active peptides and their use for repairing injured nerves

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20012082A FI20012082A0 (sv) 2001-10-26 2001-10-26 Biologiskt aktiva peptider för korrigering av nervskador

Publications (1)

Publication Number Publication Date
FI20012082A0 true FI20012082A0 (sv) 2001-10-26

Family

ID=8562134

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20012082A FI20012082A0 (sv) 2001-10-26 2001-10-26 Biologiskt aktiva peptider för korrigering av nervskador

Country Status (10)

Country Link
US (3) US20040266991A1 (sv)
EP (1) EP1438329B1 (sv)
JP (1) JP4312054B2 (sv)
AT (1) ATE490972T1 (sv)
AU (1) AU2002336124B2 (sv)
CA (1) CA2465245C (sv)
DE (1) DE60238551D1 (sv)
DK (1) DK1438329T3 (sv)
FI (1) FI20012082A0 (sv)
WO (1) WO2003035675A1 (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005029468A1 (de) * 2005-06-24 2006-12-28 Plt Patent & Licence Trading Ltd. Verwendung von Inhibitoren der N-Methyltransferasen in der Therapie des Parkinson-Syndroms
RU2301678C1 (ru) * 2006-05-30 2007-06-27 Общество С Ограниченной Ответственностью "Сиа Пептайдс" Пептид, стимулирующий регенерацию нейронов центральной нервной системы, фармацевтическая композиция на его основе и способ ее применения
BRPI0812357A2 (pt) * 2007-05-31 2015-01-27 Hertz Corp Sistema e método para gerar automaticamente um passe de embarque em avião para um viajante retornando um automóvel de aluguel
US8008253B2 (en) * 2007-07-03 2011-08-30 Andrew Tasker Treatment for anxiety
US20090247466A1 (en) * 2008-03-10 2009-10-01 University Of Louisville Research Foundation Neuroprotective integrin-binding peptide and angiopoietin-1 treatments
GB201700529D0 (en) 2017-01-12 2017-03-01 Rogers April Laminin receptor peptide

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT276041B (de) * 1968-08-16 1969-11-10 Dragoco Gerberding Co Gmbh Verfahren zur Herstellung eines konzentrierten, praktisch sterilen Rohzwiebelaromas
US3590722A (en) * 1969-06-09 1971-07-06 Samuel Leptrone Flavor injector device
HU185263B (en) 1981-06-12 1984-12-28 Richter Gedeon Vegyeszet Process for producing peptides effective on the immuncontroll analogous with the tp5
FI922517A (fi) * 1992-05-29 1993-11-30 Paeivi Liesi Nervrepareringsmedel och dess anvaendning
GB9217316D0 (en) 1992-08-14 1992-09-30 Ludwig Inst Cancer Res Schwann cell mitogenic factor,its preparation and use
GB9324473D0 (en) 1993-11-29 1994-01-12 Oxford Res Support Co Ltd Isolation of streptokinase by affinity chromatography
ES2185782T3 (es) * 1995-07-26 2003-05-01 Firmenich & Cie Productos aromatizados y procedimiento para su preparacion.
US5721256A (en) * 1997-02-12 1998-02-24 Gpi Nil Holdings, Inc. Method of using neurotrophic sulfonamide compounds
CA2307954C (en) 1997-04-03 2010-07-13 California Institute Of Technology Enzyme-medicated modification of fibrin for tissue engineering
US20020168718A1 (en) * 1997-04-03 2002-11-14 California Institute Of Technology Enzyme-mediated modification of fibrin for tissue engineering
US6075119A (en) * 1997-04-07 2000-06-13 The Rockefeller University Peptides useful for reducing symptoms of toxic shock syndrome
IL121191A0 (en) * 1997-06-29 1997-11-20 Yeda Res & Dev Synthetic peptides and pharmaceutical compositions comprising them
EP1175235A1 (en) 1999-04-22 2002-01-30 Eidgenossisch Technische Hochschule Zurich Modified protein matrices
DE20010297U1 (de) 2000-06-08 2000-08-31 Eth Zuerich Zuerich Enzymvermittelte Modifizierung von Fibrin zur Gewebemanipulation: Fibrin-Formulierungen mit Peptiden

Also Published As

Publication number Publication date
CA2465245C (en) 2012-09-11
EP1438329A1 (en) 2004-07-21
US7741436B2 (en) 2010-06-22
DK1438329T3 (da) 2011-03-28
US7659255B2 (en) 2010-02-09
US20040266991A1 (en) 2004-12-30
US20080249021A1 (en) 2008-10-09
JP2005512979A (ja) 2005-05-12
EP1438329B1 (en) 2010-12-08
ATE490972T1 (de) 2010-12-15
JP4312054B2 (ja) 2009-08-12
US20050288231A1 (en) 2005-12-29
AU2002336124B2 (en) 2008-07-03
CA2465245A1 (en) 2003-05-01
WO2003035675A1 (en) 2003-05-01
DE60238551D1 (de) 2011-01-20

Similar Documents

Publication Publication Date Title
IL161591A (en) Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
CY1111120T1 (el) Πεπτιδια που παραγονται απο πρωτεϊνες νευρικων ινων και η ιατρικη τους χρηση
WO2003008443A3 (en) Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
HK1077518A1 (en) Peptides that modulate nerve growth factor (ngf) activity, their compositions and use
WO2002080858A3 (en) Use of kpv tripeptide for dermatological disorders
CA2596597A1 (en) Method for stimulation collagen synthesis and/or kgf expression
DE60040623D1 (de) Komplementäre, synthetische peptide und ihre nutzung in der ophthalmologie
ATE218579T1 (de) Zusammensetzungen und methoden zur behandlung von infektionen unter verwendung von indolicidin- analogen
DE60331546D1 (de) Verwendung von aspartic proteasen in den bereichen kosmetik und behandlung
AU6020099A (en) Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
ATE427956T1 (de) Ckrox-peptide und ihre analoge zur behandlung von hautalterung
DE60213648D1 (de) Verwendung von thymulinähnlichen peptiden zur herstellung von schmerzmitteln
FI20012082A0 (sv) Biologiskt aktiva peptider för korrigering av nervskador
WO2001005810A3 (de) CYCLISCHE PEPTIDDERIVATE ALS INHIBITOREN DES INTEGRINS αvβ¿6?
MXPA04005079A (es) Variantes del dominio c2 del factor viii.
ATE193305T1 (de) Osteogene wachstums-oligopeptide und diese enthaltende pharmazeutische zusammensetzungen
ATE411812T1 (de) Peptide zur behandlung von infektionen mit dem herpes-virus
YU60199A (sh) Nove soli bpc peptida sa organo-zaštitnom aktivnošću, postupak za njihovo dobijanje i njihova primena u terapiji
ATE452903T1 (de) Modifizierte peptide und deren verwendung zur behandlung von autoimmunkrankheiten
WO2003044040A3 (en) Alpha-fetoprotein peptides and uses thereof
PT938329E (pt) Composicao de tlp imunogenica
NO20016341L (no) Inhibitorer for integrinet <alfa>v<beta>6
MY140828A (en) Therapeutic uses of tri-, tetra-, penta-, and polypeptides
WO2002083729A3 (en) Polypeptides derived from amyloid precursor peptide (app) and their uses
EP1714979A3 (en) Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells